Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOh, Byeongsang-
dc.contributor.authorBoyle, Frances-
dc.contributor.authorPavlakis, Nick-
dc.contributor.authorClarke, Stephen-
dc.contributor.authorGuminski, Alex-
dc.contributor.authorEade, Thomas-
dc.contributor.authorLamoury, Gillian-
dc.contributor.authorCarroll, Susan-
dc.contributor.authorMorgia, Marita-
dc.contributor.authorKneebone, Andrew-
dc.contributor.authorHruby, George-
dc.contributor.authorStevens, Mark-
dc.contributor.authorLiu, Wen-
dc.contributor.authorCorless, Brian-
dc.contributor.authorMolloy, Mark-
dc.contributor.authorLibermann, Towia-
dc.contributor.authorRosenthal, David-
dc.contributor.authorBack, Michael-
dc.description.abstractIncreasing evidence suggests that the gut microbiome is associated with both cancer chemotherapy (CTX) outcomes and adverse events (AEs). This review examines the relationship between the gut microbiome and CTX as well as the impact of CTX on the gut microbiome. A literature search was conducted in electronic databases Medline, PubMed and ScienceDirect, with searches for "cancer" and "chemotherapy" and "microbiome/microbiota". The relevant literature was selected for use in this article. Seventeen studies were selected on participants with colorectal cancer (CRC; n=5), Acute Myeloid Leukemia (AML; n=3), Non-Hodgkin's lymphoma (n=2), breast cancer (BCa; n=1), lung cancer (n=1), ovarian cancer (n=1), liver cancer (n=1), and various other types of cancers (n=3). Seven studies assessed the relationship between the gut microbiome and CTX with faecal samples collected prior to (n=3) and following CTX (n=4) showing that the gut microbiome is associated with both CTX efficacy and toxicity. Ten other prospective studies assessed the impact of CTX during treatment and found that CTX modulates the gut microbiome of people with cancer and that dysbiosis induced by the CTX is related to AEs. CTX adversely impacts the gut microbiome, inducing dysbiosis and is associated with CTX outcomes and AEs. Current evidence provides insights into the gut microbiome for clinicians, cancer survivors and the general public. More research is required to better understand and modify the impact of CTX on the gut microbiome.en
dc.description.sponsorshipRadiation Oncologyen
dc.titleEmerging Evidence of the Gut Microbiome in Chemotherapy: A Clinical Reviewen
dc.typeJournal Articleen
dc.description.affiliatesCentral Coast Local Health Districten
dc.identifier.journaltitleFrontiers in oncologyen
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristype Oncology-
Appears in Collections:Oncology / Cancer
Show simple item record

Page view(s)

checked on Sep 29, 2023

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.